An Insight Into Cervical Cancer Screening and Treatment Capacity in Sub Saharan Africa.

Coleman, Jenell S; Cespedes, Michelle S; Cu-Uvin, Susan; Kosgei, Rose J; Maloba, May; Anderson, Jean; Wilkin, Timothy; Jaquet, Antoine; Bohlius, Julia; Anastos, Kathryn; Wools-Kaloustian, Kara (2016). An Insight Into Cervical Cancer Screening and Treatment Capacity in Sub Saharan Africa. Journal of Lower Genital Tract Disease, 20(1), pp. 31-37. Lippincott Williams & Wilkins 10.1097/LGT.0000000000000165

Preview

Text Coleman JLowGenitTractDis 2016.pdf - Published Version Available under License Publisher holds Copyright. Download (840kB) | Preview

OBJECTIVE

Approximately 85% of cervical cancer cases and deaths occur in resource-constrained countries where best practices for prevention, particularly for women with HIV infection, still need to be developed. The aim of this study was to assess cervical cancer prevention capacity in select HIV clinics located in resource-constrained countries.

MATERIALS AND METHODS

A cross-sectional survey of sub-Saharan African sites of 4 National Institutes of Health-funded HIV/AIDS networks was conducted. Sites were surveyed on the availability of cervical cancer screening and treatment among women with HIV infection and without HIV infection. Descriptive statistics and χ or Fisher exact test were used as appropriate.

RESULTS

Fifty-one (65%) of 78 sites responded. Access to cervical cancer screening was reported by 49 sites (96%). Of these sites, 39 (80%) performed screening on-site. Central African sites were less likely to have screening on-site (p = .02) versus other areas. Visual inspection with acetic acid and Pap testing were the most commonly available on-site screening methods at 31 (79%) and 26 (67%) sites, respectively. High-risk HPV testing was available at 29% of sites with visual inspection with acetic acid and 50% of sites with Pap testing. Cryotherapy and radical hysterectomy were the most commonly available on-site treatment methods for premalignant and malignant lesions at 29 (74%) and 18 (46%) sites, respectively.

CONCLUSIONS

Despite limited resources, most sites surveyed had the capacity to perform cervical cancer screening and treatment. The existing infrastructure of HIV clinical and research sites may provide the ideal framework for scale-up of cervical cancer prevention in resource-constrained countries with a high burden of cervical dysplasia.

Interest & Impact

Downloads

405 since deposited on 22 Dec 2015
44 in the past 12 months

Citations

5 Citations in Web of Science ®
6 Citations in Scopus

Search

in Google Scholar™

Services

Actions (login required)

Edit item

Actions (login required)

Edit item